SUN Pharmaceutical Industries Limited Fenofibrate Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Fenofibrate Export Records India — #4 Exporter, 113 Shipments, $5.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fenofibrate

India Pharmaceutical Trade Intelligence

$73.4M168 Suppliers81 CountriesHS 30049099

ExportsIndia → UNITED STATES43.4%India → BELGIUM8.7%

ImportsUNITED STATES → India$13.3K CANADA → India$3.1K

#1 Buyer: YUSEN LOGISTICS

SUN Pharmaceutical Industries Limited — Fenofibrate Exporter #4 | $5.7M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Fenofibrate Exporter Profile

Indian Pharmaceutical Exporter · #4 for Fenofibrate · $5.7M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Fenofibrate with $5.7M in export value and 113 verified shipments. SUN Pharmaceutical Industries Limited holds a 7.7% market share in Fenofibrate exports across 10 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Fenofibrate Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Fenofibrate export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Fenofibrate?

Country	Value	Shipments	Share
BELGIUM	$1.6M	88	72.0%
BRAZIL	$154.8K	4	6.9%
PHILIPPINES	$117.7K	7	5.2%
CANADA	$97.7K	2	4.3%

Who Are the Top Buyers of Fenofibrate from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.4M	74
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$154.8K	11
SUN PHARMA CANADA INC	CANADA	$97.7K	2
M/S. RANBAXY FARMACEUTICA LTDA	BRAZIL	$69.4K	2
M S IE MEDICA INC	PHILIPPINES	$65.8K	3
SUN PHARMA ANZ PTY LTD.	AUSTRALIA	$50.0K	1
M/S. RANBAXY FARMACEUTICA LTDA,	BRAZIL	$50.0K	1
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$47.4K	3
SUN PHARMACEUTICALS MOROCCO LLC	MOROCCO	$40.7K	1
TO THE HONGKONG AND SHANGHAI BANKIN	SRI LANKA	$35.5K	2

SUN Pharmaceutical Industries Limited supplies Fenofibrate to 25 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and SUN PHARMA CANADA INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Fenofibrate Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
FENOFIBRATE CAPSULES 200MG PACK :4x7s Ba	$224.2K	6
FENOFIBRATE CAPSULES 267MG PACK : 4x7s B	$124.6K	5
FENOFIBRATE CAPSULES 200MG PACK : 4x7s B	$98.3K	6
HSN CODE:30049099 SAP CODE:1113750 TAROFENOFIBRATE E TABS 145MG E.TAB.CONT:FENOFIBRATE PH.EUR.145MG PACK : 100S BOTTL	$50.0K	1
FENOFIBRAT TERAPIA TAB 145MG PACK : BOX3X10S BATCH : MHF0350A MHF0369A EACH TABCONTS: FENOFIBRATE PH.EUR. 145MG	$50.0K	1
FENOFIBRATE RBX TAB.145MG,E.FILM COAT TAB.CON:FENOFIB.PH.EUR.145MG,PACK:Box3x10s,Batch:MHG0101A MFD: 16.01.25 EXP:31.12.	$50.0K	1
FENOFIBRATO PENSA TAB 160MG PACK : Box3x10s Batch : DFF7028B, DFF8272A EACH TABLETS CONTAINS: FENOFIBRATE PH.EUR. 160MG	$50.0K	1
FENOFIBRATE TAB 160MG 3X10b BR PACK:BOX3X10s BATCH:DFG1098A,DFG1099A EACH CONTS.FENOFIBRATE TAB 160MG	$50.0K	1
HSN CODE:30049099 SAP CODE:1113750 TAROFENOFIBRATE E TABS 145 MG EACH TABLET CONTAINS:FENOFIBRATE PH.EUR. 145 MG PACK :	$47.7K	1
STANLIP TAB 160 mg (FENOFIBRATE BP EQUIV	$47.4K	3

SUN Pharmaceutical Industries Limited exports 99 distinct Fenofibrate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FENOFIBRATE CAPSULES 200MG PACK :4x7s Ba with 6 shipments worth $224.2K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Fenofibrate Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	HETERO LABS LIMITED	$8.3M	338	8	$24.4K
3	CIPLA LIMITED	$7.1M	329	3	$21.7K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$5.7M	113	10	$50.0K
6	AJANTA PHARMA LIMITED	$4.7M	105	3	$44.7K
7	MANKIND PHARMA LIMITED	$4.2M	283	1	$14.8K

SUN Pharmaceutical Industries Limited ranks #4 among 168 Indian Fenofibrate exporters. Average shipment value of $50.0K compared to the market average of $286.5K. The closest competitors by value are HETERO LABS LIMITED and CIPLA LIMITED.

Which Indian Ports Ship Fenofibrate Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	361	12.9%
SAHAR AIR	281	10.1%
SAHAR AIR CARGO ACC (INBOM4)	229	8.2%
DELHI AIR CARGO ACC (INDEL4)	227	8.1%
JNPT/ NHAVA SHEVA SEA	203	7.3%
DELHI AIR	143	5.1%
HYDERABAD ICD	125	4.5%
JNPT	115	4.1%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Fenofibrate Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fenofibrate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 118 individual customs records matching SUN Pharmaceutical Industries Limited exporting Fenofibrate, covering 99 formulations to 10 countries via 25 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 81+ countries, 368+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fenofibrate

Fenofibrate

SUN Pharmaceutical Industries Limited — Fenofibrate Exporter Profile

SUN Pharmaceutical Industries Limited — Fenofibrate Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Fenofibrate?

Who Are the Top Buyers of Fenofibrate from SUN Pharmaceutical Industries Limited?

What Is India's Total Fenofibrate Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Fenofibrate Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Fenofibrate Exporters?

What Fenofibrate Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Fenofibrate to Key Markets

Brazil — ANVISA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Fenofibrate Exporters?

Which Indian Ports Ship Fenofibrate Exports?

Fenofibrate — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Fenofibrate Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fenofibrate Export Data from SUN Pharmaceutical Industries Limited

Fenofibrate Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source